APONTIS PHARMA AG (APPH.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:APPH - DE000A3CMGM5 - Common Stock
11 EUR
0 (0%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 48.47M | 36.96M | 55.73M | 51.18M | 39.24M | |||
| Cost Of Goods | 21.00M | 14.00M | 20.74M | 17.40M | 14.22M | |||
| Gross Profit | 27.70M | 23.17M | 34.99M | 33.79M | 25.03M | |||
| Operating Expenses | 26.00M | 32.43M | 31.73M | 29.39M | 25.50M | |||
| Selling, General, and Administrative Expenses | 17.00M | 21.00M | 20.19M | 19.68M | 18.07M | |||
| Operating Income | 1.26M | -9.43M | 3.26M | 4.39M | -480.00K | |||
| Interest Income/Expense | -115.00K | -20.00K | 0.00 | -350.00K | -810.00K | |||
| Other Income/Expense | 0.00 | 290.00K | 15.90K | -50.00K | -60.00K | |||
| Non Recurring Items | 0.00 | -5.57M | 550.00K | -3.74M | -130.00K | |||
| Income Before Taxes | 1.15M | -15.00M | 3.83M | 250.00K | -1.48M | |||
| Income Tax | 400.00K | -3.54M | 1.14M | 990.00K | -290.00K | |||
| Net Income | 750.00K | -11.00M | 2.69M | -750.00K | -1.18M | |||
| EBITDA | 3.50M | -7.55M | 5.06M | 6.14M | 1.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.09 | -1.29 | 0.32 | -0.09 | -0.14 | |||
| Statistics | ||||||||
| Gross Profit Margin | 57.16% | 62.68% | 62.79% | 66.02% | 63.79% | |||
| Profit Margin | 1.55% | -29.76% | 4.82% | -1.47% | -3.01% | |||
| Operating Profit Margin | 2.60% | -25.51% | 5.85% | 8.58% | -1.22% | |||
All data in EUR